CCND1 and lung carcinoma: Moreover, CCND1 overexpression has been reported in several cancers including lung cancer, breast cancer, colon cancer, glioblastomas, melanomas, and oral squamous cell carcinoma, with an amplification rate of approximately 40% [10].